|
1
|
Meyers PA and Gorlick R: Osteosarcoma.
Pediatr Clin North Am. 44:973–989. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Longhi A, Errani C, De Paolis M, Mercuri M
and Bacci G: Primary bone osteosarcoma in the pediatric age: State
of the art. Cancer Treat Rev. 32:423–436. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kempfbielack B, Bielack SS, Jürgens H,
Branscheid D, Berdel WE, Exner GU, Göbel U, Helmke K, Jundt G,
Kabisch H, et al: Osteosarcoma relapse after combined modality
therapy: An analysis of unselected patients in the cooperative
osteosarcoma study group (COSS). J Clin Oncol. 23:559–568. 2005.
View Article : Google Scholar
|
|
4
|
Sanger HL, Klotz G, Riesner D, Gross HJ
and Kleinschmidt AK: Viroids are single-stranded covalently closed
circular RNA molecules existing as highly base-paired rod-like
structures. Proc Natl Acad Sci USA. 73:3852–3856. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Guo JU, Agarwal V, Guo H and Bartel DP:
Expanded identification and characterization of mammalian circular
RNAs. Genome Biol. 15:4092014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li Y, Zheng Q, Bao C, Li S, Guo W, Zhao J,
Chen D, Gu J, He X and Huang S: Circular RNA is enriched and stable
in exosomes: A promising biomarker for cancer diagnosis. Cell Res.
25:981–984. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lux S and Bullinger L: Circular RNAs in
cancer. Adv Exp Mol Cancer. 1087:215–230. 2018.
|
|
8
|
Zhang M and Xin Y: Circular RNAs: A new
frontier for cancer diagnosis and therapy. J Hematol Oncol.
11:212018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sang M, Meng L, Liu S, Ding P, Chang S, Ju
Y, Liu F, Gu L, Lian Y and Geng C: Circular RNA ciRS-7 maintains
metastatic phenotypes as a ceRNA of miR-1299 to target MMPs. Mol
Cancer Res. 16:1665–1675. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wei H, Pan L, Tao D and Li R: Circular RNA
circZFR contributes to papillary thyroid cancer cell proliferation
and invasion by sponging miR-1261 and facilitating C8orf4
expression. Biochem Biophys Res Commun. 503:56–61. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhong Y, Du Y, Yang X, Mo Y, Fan C, Xiong
F, Ren D, Ye X, Li C, Wang Y, et al: Circular RNAs function as
ceRNAs to regulate and control human cancer progression. Mol
Cancer. 17:792018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Huang L, Chen M, Pan J and Yu W: Circular
RNA circNASP modulates the malignant behaviors in osteosarcoma via
miR-1253/FOXF1 pathway. Biochem Biophys Res Commun. 500:511–517.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yanbin Z and Jing Z: CircSAMD4A
accelerates cell proliferation of osteosarcoma by sponging miR-1244
and regulating MDM2 mRNA expression. Biochem Biophys Res Commun.
516:102–111. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Qi W, Liang W, Jiang H and Miuyee Waye M:
The function of miRNA in hepatic cancer stem cell. Biomed Res Int.
2013:3589022013. View Article : Google Scholar
|
|
15
|
Chi SW, Zang JB, Mele A and Darnell RB:
Ago HITS-CLIP decodes miRNA-mRNA interaction maps. Nature.
460:479–486. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Allantaz F, Cheng DT, Bergauer T,
Ravindran P, Rossier MF, Ebeling M, Badi L, Reis B, Bitter H,
D'Asaro M, et al: Expression profiling of human immune cell subsets
identifies miRNA-mRNA regulatory relationships correlated with cell
type specific expression. PLoS One. 7:e299792012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Althoff K, Lindner S, Odersky A, Mestdagh
P, Beckers A, Karczewski S, Molenaar JJ, Bohrer A, Knauer S,
Speleman F, et al: miR-542-3p exerts tumor suppressive functions in
neuroblastoma by downregulating Survivin. Int J Cancer.
136:1308–1320. 2015. View Article : Google Scholar
|
|
18
|
Chen Y, Han X, Yin X, Zhou Y and Wu T:
Decreased expression of miR-132 in CRC tissues and its inhibitory
function on tumor progression. Open Life Sci. 11:130–135. 2016.
View Article : Google Scholar
|
|
19
|
Liu W, Kang L, Han J, Wang Y, Shen C, Yan
Z, Tai Y and Zhao C: miR-342-3p suppresses hepatocellular carcinoma
proliferation through inhibition of IGF-1R-mediated Warburg effect.
Onco Targets Ther. 11:1643–1653. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen H and Tian Y: MiR-15a-5p regulates
viability and matrix degradation of human osteoarthritis
chondrocytes via targeting VEGFA. Biosci Trends. 10:482–488. 2017.
View Article : Google Scholar
|
|
21
|
Chang SW, Yue J, Wang BC and Zhang XL:
miR-503 inhibits cell proliferation and induces apoptosis in
colorectal cancer cells by targeting E2F3. Int J Clin Exp Pathol.
8:12853–12860. 2015.
|
|
22
|
Hussein NA, Kholy ZA, Anwar MM, Ahmad MA
and Ahmad SM: Plasma miR-22-3p miR-642b-3p and miR-885-5p as
diagnostic biomarkers for pancreatic cancer. J Cancer Res Clin
Oncol. 143:83–93. 2017. View Article : Google Scholar
|
|
23
|
Kong XY, Du YQ Li L, Liu JQ, Wang GK, Zhu
JQ, Man XH, Gong YF, Xiao LN, Zheng YZ, et al: Plasma miR-216a as a
potential marker of pancreatic injury in a rat model of acute
pancreatitis. World J Gastroenterol. 16:4599–4604. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu BR and Xie L: microRNA: A new cancer
biomarker. Chin Clin Oncol. 15:1–5. 2010.In Chinese.
|
|
25
|
Li Q, Song S, Ni G, Li Y and Wang X: Serum
miR-542-3p as a prognostic biomarker in osteosarcoma. Cancer
Biomark. 21:521–526. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tao K, Yang J, Guo Z, Hu Y, Sheng H, Gao H
and Yu H: Prognostic value of miR-221-3p miR-342-3p and miR-491-5p
expression in colon cancer. Am J Transl Res. 6:391–401. 2014.
|
|
27
|
Wang D, Fan Z, Liu F and Zuo J: Hsa-miR-21
and Hsa-miR-29 in tissue as potential diagnostic and prognostic
biomarkers for gastric cancer. Cell Physiol Biochem. 37:1454–1462.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
29
|
Li C, Wang F, Wei B, Wang L and Kong D:
LncRNA AWPPH promotes osteosarcoma progression via activation of
Wnt/β-catenin pathway through modulating miR-93-3p/FZD7 axis.
Biochem Biophys Res Commun. 514:1017–1022. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yilmaz M and Christofori G: EMT, the
cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev.
28:15–33. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jin H, Jin X, Zhang H and Wang W: Circular
RNA hsacirc-0016347- promotes proliferation, invasion and
metastasis of osteosarcoma cells. Oncotarget. 8:25571–25581. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Jin J, Chen A, Qiu W, Chen Y, Li Q, Zhou X
and Jin D: Dysregulated circRNA_100876 suppresses proliferation of
osteosarcoma cancer cells by targeting microRNA-136. J Cell
Biochem. 120:15678–15687. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Pan Z, Sun X, Shan H, Wang N, Wang J, Ren
J, Feng S, Xie L, Lu C, Yuan Y, et al: MicroRNA-101 inhibited
postinfarct cardiac fibrosis and improved left ventricular
compliance via the FBJ osteosarcoma oncogene/transforming growth
factor-β1 pathway. Circulation. 126:840–850. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liu X, Zhong Y, Li J and Shan A: Circular
RNA circ-NT5C2 acts as an oncogene in osteosarcoma proliferation
and metastasis through targeting miR-448. Oncotarget.
8:114829–114838. 2017. View Article : Google Scholar
|
|
35
|
Cheng D, Fan J, Ma Y, Zhou Y, Qin K, Shi M
and Yang J: LncRNA SNHG7 promotes pancreatic cancer proliferation
through ID4 by sponging miR-342-3p. Cell Biosci. 9:282019.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gao Y, Zhang SG, Wang ZH and Liao JC:
Down-regulation of miR-342-3p in hepatocellular carcinoma tissues
and its prognostic significance. Eur Rev Med Pharmacol Sci.
21:2098–2102. 2017.PubMed/NCBI
|
|
37
|
Hu K, Mu X, Kolibaba H, Yin Q, Liu C,
Liang X and Lu J: Metadherin is an apoptotic modulator in prostate
cancer through miR-342-3p regulation. Saudi J Biol Sci. 25:975–981.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Jones D, Anene D, Aloway A, Anene P, Avila
D, Gobejishvili L, Barve S, Mcnally L and Kidd LC: Abstract 1844:
Reduced expression of miR-342-3p in prostate cancer. Cancer Res.
73:1844. 2013.
|
|
39
|
Zhang S, Liu L, Lv Z, Li Q, Gong W and Wu
H: MicroRNA-342-3p inhibits the proliferation, migration, and
invasion of osteosarcoma cells by targeting astrocyte-elevated
gene-1 (AEG-1). Oncol Res. 25:1505–1515. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Asad M, Wong MK, Tan TZ, Choolani M, Low
J, Mori S, Virshup D, Thiery JP and Huang RY: FZD7 drives in vitro
aggressiveness in Stem-A subtype of ovarian cancer via regulation
of non-canonical Wnt/PCP pathway. Cell Death Dis. 5:e13462014.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Deng B, Zhang Y, Zhang S, Wen F, Miao Y
and Guo K: MicroRNA-142-3p inhibits cell proliferation and invasion
of cervical cancer cells by targeting FZD7. Tumor Biol.
36:8065–8073. 2015. View Article : Google Scholar
|
|
42
|
Kirikoshi H, Sekihara H and Katoh M:
Up-regulation of Frizzled-7 (FZD7) in human gastric cancer. Int J
Oncol. 19:111–115. 2001.PubMed/NCBI
|
|
43
|
Qiu X, Jiao J, Li Y and Tian T:
Overexpression of FZD7 promotes glioma cell proliferation by
upregulating TAZ. Oncotarget. 7:85987–85999. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Cao TT, Xiang D, Liu BL, Huang TX, Tan BB,
Zeng CM, Wang ZY, Ming XY, Zhang LY, Jin G, et al: FZD7 is a novel
prognostic marker and promotes tumor metastasis via WNT and EMT
signaling pathways in esophageal squamous cell carcinoma.
Oncotarget. 8:65957–65968. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Cheng ZX, Song YX, Wang ZY, Wang Y and
Dong Y: miR-144-3p serves as a tumor suppressor by targeting FZD7
and predicts the prognosis of human glioblastoma. Eur Rev Med
Pharmacol Sci. 21:4079–4086. 2017.PubMed/NCBI
|
|
46
|
Chen Z, Huang C, Ma T, Jiang L, Tang L,
Shi T, Zhang S, Zhang L, Zhu P, Li J and Shen A: Reversal effect of
quercetin on multidrug resistance via FZD7/β-catenin pathway in
hepatocellular carcinoma cells. Phytomedicine. 43:37–45. 2018.
View Article : Google Scholar : PubMed/NCBI
|
